Site Search
410 result(s) found for “ adaptive therapy”
-
Moffitt Named a Comprehensive Radiopharmaceutical Therapy Center of Excellence by SNMMI
Moffitt is one of only 29 academic centers in the U.S. designated as a Comprehensive Radiopharmaceutical Therapy Center of Excellence.
-
Moffitt Treats its First Commercial TIL Therapy Patient Since FDA Approval
The one-time T-cell therapy infusion was approved in February
-
Moffitt is First in U.S. to Offer New Lung Cancer Therapy
FDA recently approved tarlatamab for extensive stage small cell lung cancer
-
Overcoming Rare Synovial Sarcoma with a Revolutionary New Treatment
After years of treatments, a first-of-its-kind cell therapy is offering new possibilities for one synovial sarcoma patient
-
Study Shows Combined Therapy Helps Advanced Colorectal Cancer Patients Live Longer
Patients receiving trial medications had a 65.7% partial or complete response to treatment
-
Targeted Therapy Shows Promise as Earlier Treatment for Metastatic Breast Cancer
Enhertu proves effective in HER2-low metastatic breast cancer with disease progression after endocrine therapy
-
Combination Therapy Before Surgery Shows Promise for Aggressive Skin Cancer
Moffitt-led study explores how pairing lenvatinib and pembrolizumab strengthens immune response against Merkel cell carcinoma
-
Is Proton Therapy Better for Head and Neck Cancer Patients?
Study shows proton radiation increases survival outcomes in patients with HPV-related cancers
-
Moffitt Researcher Explores Why Black Women Stop Taking Hormone Therapy
Many breast cancer patients are prescribed to take medication daily for five to 10 years to reduce recurrence
-
Radiation Therapy Can Reduce Symptoms in Patients With Leptomeningeal Disease
Study showed intensity-modulated radiation craniospinal irradiation improved side effects in 77% of patients